Abstract
Purpose
Hadrontherapy, the technique that uses charged particles, is an area in which scientific insight, technological advancement, research and collaboration are mutually beneficial and inspirational for the benefit of the patient. The oncological treatment of patients has become a multidisciplinary effort, in which the contribution of specialists from manifold backgrounds is essential, and only a transdisciplinary “fusion”, an integration and overlap across relevant disciplines, can be successful. The purpose of this contribution is to describe the Centre for Oncological Hadron therapy (CNAO) main features and activities.
Methods
CNAO is among the six centers worldwide and the fourth in Europe that provide protons and carbon ions for the treatment of tumors.
Results
CNAO represents a centre of excellence, supported by the Italian Ministry of Health and the Lombardy Region Approximately 5000 patients have been treated successfully, several research projects are underway to enhance treatment outcomes and in the near future, new modalities will be launched.
Conclusions
In this respect, CNAO is at the forefront and BNCT represents and additional viable option in the treatment of disseminated tumours.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
There is no original data in this manuscript.
References
Saverwein W, et al. Neutron capture therapy: principles and applications. Berlin/Heidelberg, Germany: Springer-Verlag; 2012. https://doi.org/10.1007/978-3-642-31334-9.
Suzuki M. Boron Neutron Capture Therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era. Int J Clin Oncol. 2020;2020(25):43–50. https://doi.org/10.1007/s10147-019-01480-4.
Zonta A, et al. Clinical lessons from the first applications of BNCT on unresectable liver metastases. J of Phys, Conf Series. 2006;41:484–95.
Zonta A, et al. Extra corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned. Appl Radiat Isot. 2009;67:67–70.
Rossi S. Ions for the treatment of tumours. In oxford research encyclopedia of physics. Ed. Brian Foster. New York: Oxford University Press, in press.
Rossi S. Hadron therapy achievements and challenges: the CNAO experience. Physics. 2022;2022(4):229–57. https://doi.org/10.3390/physics4010017.
Ebner D, et al. The emerging potential of multi-ion radiotherapy. Front Oncol. 2021. https://doi.org/10.3389/fonc.2021.624786.
Molinelli S, et al. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy. Radiother Oncol. 2021;163:209–14. https://doi.org/10.1016/j.radonc.2021.08.024.
Kamlah F, et al. Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma Cells. Int J Radiat Oncol Biol Phys. 2011;80(5):1541–9. https://doi.org/10.1016/j.ijrobp.2011.03.033.
Ogata T, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;1(65):113–20.
Durante M, Brenner DJ, Formenti SC. Does heavy ion therapy work through the immune system? Int J Radiat Oncol Biol Phys. 2016;96:934–6. https://doi.org/10.1016/j.ijrobp.2016.08.037.
Friedrich T, Henthorn N, Durante M. Modeling radioimmune response-current status and perspectives. Front: Oncol; 2021. https://doi.org/10.3389/fonc.2021.647272.
Benedetto E, et al. A carbon ion superconducting gantry and a synchrotron based on canted cosine-theta magnets. arXiv preprint arXiv:2105.04205. 2021. https://doi.org/10.48550/arXiv.2105.04205.
Amaldi U, et al. SIGRUM - A Superconducting ion gantry with riboni’s unconventional mechanics. CERN Tech Rep 2021. https://cds.cern.ch/record/2766876.
Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol. 2012;57(11):R99. https://doi.org/10.1088/0031-9155/57/11/R99.
Parodi K. On-and off-line monitoring of ion beam treatment. Nucl Instrum Methods Phys Res, Sect A. 2016;809:113–9.
Bisogni MG. The INSIDE bimodal system for range monitoring in particle therapy toward clinical validation. Nucl Instrum Meth Phys Res A: Accel Spectrom Detect Assoc Equip. 2019;936:73–4. https://doi.org/10.1016/j.nima.2018.11.048.
Fiorina E, et al. Detection of interfractional morphological changes in proton therapy: A simulation and in vivo study with the INSIDE in-beam PET. Front Phys. 2021;8:660.
Kraan AC, et al. Localization of anatomical changes in patients during proton theraphy with in-beam PET monitoring: A Voxel Based Morphometry approach exploiting Monte Carlo simulations. Med Phys. 2022;49:23–40.
Fischetti M, et al. Inter-fractional monitoring of 12C ions treatments: results from a clinical trial at the CNAO facility. Sci Rep. 2020;10(1):1–11. https://doi.org/10.1038/s41598-020-77843-z.
Toppi M, et al. Monitoring carbon ion beams transverse position detecting charged secondary fragments: Results from patient treatment performed at CNAO. Front Oncol. 2021;11: 601784. https://doi.org/10.3389/fonc.2021.601784.
Buizza G, et al. Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma. Cancers. 2021;13:339. https://doi.org/10.3390/cancers13020339.
Rossi S, Serra A Eds. The boron neutron capture therapy project at CNAO. 2023; ISBN: 2023;979–12–210–4294–8.
Acknowledgements
Part of the work at CNAO has been supported also by European Union’s Horizon 2020 research and innovation program under grant agreement No 101008548 (HITRIplus).
Funding
The author(s) have received no funding for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
No Ethical Approval was required for this article.
Consent to Participate
No Consent to Participate was required for this article.
Consent to Publish
No Consent to Publish was required for this article.
Conflict of interests
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rossi, S. BNCT@CNAO: is CNAO the right place to experiment with BNCT ?. Health Technol. (2024). https://doi.org/10.1007/s12553-024-00860-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12553-024-00860-9